Summit Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.74M Buy
168,703
+27,596
+20% +$735K 0.06% 330
2025
Q4
$3.51M Buy
141,107
+16,520
+13% +$417K 0.05% 339
2025
Q3
$3.17M Buy
124,587
+5,088
+4% +$126K 0.05% 361
2025
Q2
$2.9M Buy
119,499
+25,772
+27% +$601K 0.07% 239
2025
Q1
$2.38M Buy
93,727
+15,582
+20% +$408K 0.07% 233
2024
Q4
$2.07M Buy
78,145
+46,601
+148% +$1.26M 0.07% 205
2024
Q3
$913K Buy
31,544
+2,098
+7% +$61.2K 0.04% 275
2024
Q2
$824K Buy
29,446
+14,703
+100% +$405K 0.04% 258
2024
Q1
$409K Sell
14,743
-1,399
-9% -$38.8K 0.02% 285
2023
Q4
$465K Sell
16,142
-1,057
-6% -$32K 0.03% 250
2023
Q3
$571K Buy
17,199
+3,721
+28% +$132K 0.04% 224
2023
Q2
$494K Buy
13,478
+2,999
+29% +$117K 0.04% 222
2023
Q1
$428K Sell
10,479
-32
-0.3% -$1.38K 0.04% 186
2022
Q4
$539K Sell
10,511
-1,921
-15% -$92.1K 0.05% 160
2022
Q3
$544K Sell
12,432
-14,866
-54% -$722K 0.05% 162
2022
Q2
$1.43M Sell
27,298
-590
-2% -$30.1K 0.13% 72
2022
Q1
$1.44M Buy
27,888
+12,304
+79% +$638K 0.11% 88
2021
Q4
$920K Buy
15,584
+2,442
+19% +$121K 0.07% 115
2021
Q3
$565K Buy
13,142
+4,454
+51% +$197K 0.05% 133
2021
Q2
$340K Buy
+8,688
New +$338K 0.03% 117

Other funds holding PFE

Summit Financial's PFE Position: Q1 2026 in Review

Summit Financial increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $735K and bringing the position to 168,703 shares worth $4.74M. The position accounts for 0.06% of the portfolio, ranked #330.

Summit Financial first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Summit Financial held 168,703 shares of Pfizer worth $4.74M as of Q1 2026.
  • Summit Financial bought 27,596 Pfizer shares in Q1 2026, an estimated $735K.
  • Pfizer made up 0.06% of Summit Financial's portfolio in Q1 2026, its #330 holding.
  • Summit Financial first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.